Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02577731 · ClinicalTrials.gov registry record · NA
Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury
A NA study of Trauma Injury, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT02577731 is a NA study of Trauma Injury that is actively recruiting participants, run by University of Florida. The registered enrollment target is 400 participants, below the 474-participant average among 15 other Trauma Injury trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02577731, a NA study of Trauma Injury, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
Traumatic injury is a leading cause of morbidity and mortality in young adults, and remains a substantial economic and health care burden. Despite decades of promising preclinical and clinical investigations in trauma, investigators understanding of these entities is still incomplete, and few therapies have shown success. During severe trauma, bone marrow granulocyte stores are rapidly released into the peripheral circulation. This release subsequently induces the expansion and repopulation of empty or evacuated space by hematopoietic stem cells (HSCs). Although the patient experiences an early loss of bone marrow myeloid-derived cells, stem cell expansion is largely skewed towards the repopulation of the myeloid lineage/compartment. The hypothesis is that this 'emergency myelopoiesis' is critical for the survival of the severely traumatized and further, failure of the emergency myelopoietic response is associated with global immunosuppression and susceptibility to secondary infection. Also, identifying the release of myeloid derived suppressor cells (MDSCs) in the circulation of human severe trauma subjects. This process is driven by HSCs in the bone marrow of trauma subjects. Additionally, MDSCs may have a profound effect on the nutritional status of the host. The appearance of these MDSCs after trauma is associated with a loss of muscle tissue in these subjects. This muscle loss and possible increased catabolism have huge effects on long term outcomes for these subjects. It is the investigator's goal to understand the differences that occur in these in HSCs and muscle cells as opposed to non-injured and non-infected controls. This work will lead to a better understanding of the myelopoietic and catabolic response following trauma.
Conditions Studied
Interventions
- OTHER Blood collection
- OTHER Bone marrow collection
- OTHER Clinical data collection
Study Locations (1)
Florida
- UF Health Shands Hospital at the University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2014-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02577731
The ClinicalTrials.gov registry entry for NCT02577731 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 15 other Trauma Injury trials with a reported enrollment target (16% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trauma Injury appearing as the primary indexed condition, and to 3 interventions - of which Blood collection is the first listed.
NCT02577731 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02577731 about?
NCT02577731 is a clinical study titled "Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury". Traumatic injury is a leading cause of morbidity and mortality in young adults, and remains a substantial economic and health care burden. Despite decades of promising preclinical and clinical investigations in trauma, investigators understanding of these entities is still incomplete, and few therap...
What is the current status of trial NCT02577731?
This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2014-01. Estimated completion is 2027-12-31.
What conditions does trial NCT02577731 study?
This clinical trial studies the following conditions: Trauma Injury.
What interventions are being tested in trial NCT02577731?
The interventions under investigation include: Blood collection (OTHER), Bone marrow collection (OTHER), Clinical data collection (OTHER).
Who is sponsoring clinical trial NCT02577731?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02577731 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trauma Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapy Dog Visits for Patients Hospitalized With Traumatic Injuries
RECRUITING · NA
-
Bioimpedance for Ortho Trauma
RECRUITING · NA
-
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
RECRUITING · NA
-
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
RECRUITING · NA
-
The Effects of Footplate Stiffness on Foot Loading Within Carbon Fiber Custom Dynamic Orthoses
RECRUITING · NA
-
Using mHealth to Improve Emotional Recovery After Pediatric Injury
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.